{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:30:06Z","timestamp":1792571406302,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.02.078","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T09:14:50Z","timestamp":1236676490000},"page":"1655-1660","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270"],"prefix":"10.1016","volume":"28","author":[{"given":"Zhizhen","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benchuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baizhong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.078_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/08998280.2005.11928049","article-title":"Plague: from natural disease to bioterrorism","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"16","key":"10.1016\/j.vaccine.2009.02.078_bib3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.02.078_bib4","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.vaccine.2006.01.031","article-title":"Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery","volume":"24","author":"Tripathi","year":"2006","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2009.02.078_bib5","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.vaccine.2004.01.007","article-title":"A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice","volume":"22","author":"Morton","year":"2004","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.02.078_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.02.078_bib7","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.078_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.vaccine.2003.09.020","article-title":"Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen","volume":"22","author":"Garmory","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infect Immun"},{"issue":"26","key":"10.1016\/j.vaccine.2009.02.078_bib10","first-page":"1","article-title":"Ensuring safety of DNA vaccines","volume":"4","author":"Wessels","year":"2005","journal-title":"Microbial Cell Factories"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.078_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.078_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1574-695X.2000.tb01426.x","article-title":"Identification of immunodominant epitope of F1 antigen of Yersinia pestis","volume":"27","author":"Sabhnani","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.078_bib13","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1128\/IAI.00034-08","article-title":"Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain","volume":"76","author":"Blisnick","year":"2008","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2009.02.078_bib14","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2004.10.025","article-title":"Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens","volume":"23","author":"Glynn","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.078_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.femsim.2004.10.012","article-title":"Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine","volume":"43","author":"Griffin","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"28","key":"10.1016\/j.vaccine.2009.02.078_bib16","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.078_bib17","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/IAI.73.8.5256-5261.2005","article-title":"Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens","volume":"73","author":"Glynn","year":"2005","journal-title":"Infect Immun"},{"issue":"13","key":"10.1016\/j.vaccine.2009.02.078_bib18","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.vaccine.2005.11.047","article-title":"Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague","volume":"24","author":"Reed","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2006.12.018","article-title":"Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague","volume":"53","author":"Goodin","year":"2007","journal-title":"Protein Expr Purif"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.02.078_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0264-410X(00)00108-0","article-title":"Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains","volume":"19","author":"Jones","year":"2000","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.078_bib21","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal Protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2009.02.078_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.078_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2006.09.052","article-title":"Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague","volume":"25","author":"Williamson","year":"2007","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.02.078_bib24","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","article-title":"Protective efficacy of a fully recombinant plague vaccine in the guinea pig","volume":"21","author":"Jones","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.078_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2009.02.078_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.078_bib27","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.133.4.2226","article-title":"Roles of V antigen in promoting virulence and immunity in yersiniae","volume":"133","author":"Une","year":"1984","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.61.1.23-31.1993","article-title":"Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha","volume":"61","author":"Nakajima","year":"1993","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.078_bib29","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/IAI.63.8.3021-3029.1995","article-title":"Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization","volume":"63","author":"Nakajima","year":"1995","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.078_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.65.4.1196-1203.1997","article-title":"Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10","volume":"65","author":"Nedialkov","year":"1997","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.078_bib31","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1128\/IAI.73.8.5152-5159.2005","article-title":"LcrV plague vaccine with altered immunomodulatory properties","volume":"73","author":"Overheim","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.078_bib32","first-page":"663","article-title":"Cloning and expression of Yersinia pestis rV270 antigen and efficacy against Y. pestis vir\u03bclent strain challenge","volume":"19","author":"Wang Tang","year":"2008","journal-title":"Lett Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pep.2008.05.003","article-title":"A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge","volume":"61","author":"Wang","year":"2008","journal-title":"Protein Expr Purif"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.078_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CDLI.4.5.587-591.1997","article-title":"Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar","volume":"4","author":"Rasoamanana","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.078_bib35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1248\/bpb.27.1483","article-title":"Development of novel drug delivery system (DDS) technologies for proteomic-based drug development","volume":"27","author":"Hiroko Shibata","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.vaccine.2009.02.078_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Bali Pulendran","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2009.02.078_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0020-7519(03)00066-3","article-title":"The effectiveness and limitations of immune memory: understanding protective immune responses","volume":"33","author":"Manuel Campos","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2009.02.078_bib38","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/eji.200324576","article-title":"CD4 T cells are required for CD8 T cell memory generation","volume":"33","author":"Christine Bourgeois","year":"2003","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.078_bib40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.02.078_bib41","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.078_bib42","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with Live Yersinia pestis Primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-5-38","article-title":"Immunization of mice with YscF provides protection from Yersinia pestis infections","volume":"5","author":"Matson","year":"2005","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pep.2005.02.016","article-title":"Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague","volume":"42","author":"Swietnicki","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.078_bib45","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis","volume":"67","author":"Andrews","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.078_bib46","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.02.078_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00189-08","article-title":"Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis","author":"Ivanov","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Do","year":"2008","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.078_bib49","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1128\/IAI.01860-05","article-title":"Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV","volume":"74","author":"DeBord","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.078_bib50","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.078_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2009.02.078_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00034-08","article-title":"Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis","author":"Blisnick","year":"2008","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.078_bib53","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.0510014103","article-title":"Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system","volume":"103","author":"Santi","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T09:14:23Z","timestamp":1684919663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09003429"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}